In animal studies, bortezomib not only suppressed the growth of NB cells injected into mice (249) but also induced apoptosis in human medulloblastoma cells by inhibiting key signaling pathways, including AKT and NF−κB (250). The gene discussed is AKT1; the disease is medulloblastoma.